Bal Pharma - News
NSE: BALPHARMA | BSE: 524824
₹100.67
As on 18-Sep-2026IST
Market cap
₹160 Cr
Revenue (TTM)
₹334 Cr
P/E Ratio
22.1
P/B Ratio
1.9
Div. Yield
1.2 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsClarification Regarding Movement In Price
10-Sep-2026Clarification sought from Bal Pharma Ltd
10-Sep-2026Intimation Of Record Date For Final Dividend
27-Aug-2026Bal Pharma Limited - Notice Of AGM
26-Aug-2026No News & Announcements are available.